[Risk Assessment in the Therapy for Osteomyelitis using Immunological Parameters]

Area of Science:

• Immunology
• Infectious Diseases
• Surgical Infections

Context:

• Osteomyelitis treatment involves surgery and antibiotics.
• Prolonged therapy courses can occur without clear clinical reasons.
• Identifying at-risk patients is crucial for optimizing treatment.

Purpose:

• To investigate if immunological assessments can detect patients at risk for prolonged osteomyelitis treatment.
• To explore if immunological features can guide individualized therapeutic strategies.

Summary:

• A study of 20 chronic osteomyelitis patients found lower double-negative T cell and cytotoxic T cell counts in those with prolonged disease courses.
• ROC analysis showed double-negative T cells effectively discriminated septic complications (AUC 0.88).
• Elispot testing indicated tetanus toxoid reactivity was also a potential marker (AUC 0.76).

Impact:

• Immunological markers, particularly double-negative T cells, may help identify high-risk osteomyelitis patients.
• This could lead to more personalized treatment plans.
• Further research is needed to validate these findings in larger cohorts.